Related Experiment Video
Updated: Jul 16, 2026
04:50
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Iatrogenic rheumatic syndromes in the elderly.
G Andres Quiceno1, John J Cush
1Presbyterian Hospital of Dallas, 8200 Walnut Hill Lane, Dallas, TX 75231-4496, USA.
Rheumatic Diseases Clinics of North America
|March 21, 2007
Summary
Drug side effects can cause rheumatic conditions in older adults. This review covers drug-induced myopathy, lupus, arthralgias, vasculitis, and tight skin syndromes in the elderly.
Area of Science:
- Geriatric Medicine
- Rheumatology
- Clinical Pharmacology
Background:
- Rheumatic complaints are frequent in elderly individuals.
- Medications can rarely trigger autoimmune or musculoskeletal issues.
- These drug-induced conditions are often overlooked.
Purpose of the Study:
- To review iatrogenic causes of rheumatic conditions in the elderly.
- To identify potential drug-related inciting agents.
- To describe various rheumatic manifestations resulting from pharmacotherapy.
Main Methods:
- Literature review of drug-induced rheumatic disorders in geriatric patients.
- Analysis of case reports and clinical studies.
- Synthesis of information on specific conditions and causative agents.
Main Results:
- Pharmacotherapy can lead to rare rheumatic conditions like statin myopathy.
- Drug-induced lupus, arthralgias, vasculitis, and tight skin syndromes are discussed.
- Identifying the causative agent is crucial for management.
Conclusions:
- Clinicians should consider medication side effects in elderly patients presenting with rheumatic symptoms.
- Awareness of drug-induced rheumatic conditions is essential for accurate diagnosis and treatment.
- Further research is needed to elucidate mechanisms and improve prevention strategies.
Related Concept Videos
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:20Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...